The FDA has approved the first generic of a common treatment option for asthma in patients and for maintenance treatment of airflow obstruction and reduction of exacerbations in patients with chronic...
An advisory panel to the FDA has recommended the approval of a new treatment option for use in postmenopausal women with osteoporosis and high fracture risk.
The FDA has approved a selective serotonin-4 (5-HT4) receptor agonist to treat adults with chronic idiopathic constipation, a condition that affects 14% of the adult population.
The FDA has released a warning about the potential for an increase in disability in patients with multiple sclerosis who stop taking this immunosuppressant.
The FDA has reviewed and approved a qualified health claim for certain edible oils containing high levels of a monosaturated fat shown to have cardiovascular benefits.
The antibacterial drug is approved to treat travelers’ diarrhea, which is defined as having 3 or more unformed stools in 24 hours, in a person who is traveling.
In response to the release of a CDC report detailing increases in the use of e-cigarettes among youth in the US between 2011 and 2018, the FDA has released a statement detailing new limitations to the sale...
The American Thoracic Society says the FDA approved the asthma treatment with lack of consideration for patient safety and for a public policy process.
